Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Good afternoon, everyone. Thank you for standing by. Welcome to ...

Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.

The government shutdown has thrown many parts of the country into disarray. Furloughed federal workers aren’t getting paychecks, people on the Supplemental Nutrition Assistance Program aren’t getting ...

SOL-R, the second registrational trial of AXPAXLI™ in wet AMD, remains on track for topline data in 1H 2027Together with SOL-1, these ...

The headline statistics we currently employ to understand America’s economy are profoundly misleading and, unfortunately, ...

Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...

As the C language, which forms the basis of critical global software like operating systems, faces security limitations, ...

Research and development expenses for the third quarter of 2025 were $52.4 million versus $37.1 million for the comparable quarter in 2024, reflecting an increase in overall clinical expenses ...

Flu season is developing in Florida and it takes about two weeks for your flu shots to take effect, so experts say to get yours soon.

Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and ...

As federal immigration agents carry out the president's “Operation Midway Blitz” in Democrat-led Illinois — a "blue state" — ...